Evidence map›Paper›PMID 34028656›Full record

Trial reportJournal of clinical psychology in medical settings2022

Predictors of Improvement in Pediatric Chronic Migraine: Results from the Cognitive-Behavioral Therapy and Amitriptyline Trial.

Eman K Rettig, Gokce Ergun, Janeece R Warfield, Shalonda K Slater, Susan L LeCates, Marielle A Kabbouche, Joanne Kacperski, Andrew D Hershey, Scott W Powers

Registry-linked trialAbstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Journal of clinical psychology in medical settings, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00389038 (Drug and Non-Drug Treatment of Pediatric Chronic Headache), which is not on this map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00389038 phase3unknown statusnot on this map

Drug and Non-Drug Treatment of Pediatric Chronic Headache

TypeinterventionalSponsorChildren's Hospital Medical Center, CincinnatiRan2006 to 2012Enrolled132ConditionsHeadacheArmsCoping Skills Training, Headache Education, Amitriptyline
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Eman K RettigSchool of Professional Psychology, Wright State University, Dayton, OH, USA. EKRettig11@gmail.com.
Gokce ErgunSchool of Professional Psychology, Wright State University, Dayton, OH, USA.
Janeece R WarfieldSchool of Professional Psychology, Wright State University, Dayton, OH, USA.
Shalonda K SlaterDivision of Behavioral Medicine & Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Susan L LeCatesDivision of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Marielle A KabboucheDivision of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Joanne KacperskiDivision of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Andrew D HersheyDivision of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Scott W PowersDivision of Behavioral Medicine & Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Funding

Drug & Non-Drug Treatment of Pediatric Chronic HeadacheR01NS050536 · NINDS · CINCINNATI CHILDRENS HOSP MED CTR · PI POWERS, SCOTT W · 2006 to 2009
$1.9M
NINDS NIH HHS R01 NS050536
6 · The paper itself

Abstract

Explore predictors of improvement in headache days and migraine-related disability through a secondary analysis of the cognitive-behavioral therapy plus amitriptyline trial in children and adolescents (Clinical Trials Registration Number: NCT00389038). Participants were 135 youth aged 10-17 years old diagnosed with chronic migraine. Predictor variables included group assignment (treatment or control), baseline scores from depression and quality of life measures, and demographic variables. Criterion variables included headache days and migraine-related disability. Higher baseline depression scores were indicative of more days with headache post-treatment regardless of group assignment. Family income at the higher-end of the low-income range was significantly associated with less migraine-related disability regardless of group assignment (Household Income: HINC-01 in The United States Census Bureau. Bureau, U, 2020). Results from this secondary analysis identify depression symptoms and family income as predictors that can impact headache frequency and migraine-related disability. Self-reported symptoms of depression and family income are important factors to consider as part of the biopsychosocial model of care.

Indexed as

Cognitive Behavioral TherapyMigraine DisordersAdolescentAmitriptylineChildHeadacheHumansQuality of LifeUnited StatesAmitriptylineAdolescentsChildrenDepressionFamily incomeMigrainePain

Identifiers

PMID34028656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.